In recent clinical trials, treatment with EPA monotherapy as well as with mixed EPA/DHA formulations have been associated with increased rates of AF.46,60,64,172 This finding seems to implicate O3FA-mediated AF increases independent of Piezo1. This evidence concerns the gene PIEZO1 and atrial fibrillation.